Fibrinolytic Biomarkers Can Identify Patients at Risk of Severe COVID
Researchers found that proteins regulating plasminogen-plasmin levels can be used as biomarkers to identify those at risk or severe COVID.
Read MorePosted by Andy Lundin | Mar 7, 2024 | Covid 19 |
Researchers found that proteins regulating plasminogen-plasmin levels can be used as biomarkers to identify those at risk or severe COVID.
Read MorePosted by Andy Lundin | Mar 7, 2024 | Company News |
Bruker Corporation has entered into a definitive share purchase agreement with TecFin S.à r.l. to acquire ELITechGroup.
Read MorePosted by Chris Wolski | Mar 5, 2024 | Diagnostic Technologies |
While routine testing showed gains, clinical lab volumes for other specialties have either remained flat or have exhibited ebbs and flows.
Read MorePosted by Andy Lundin | Mar 5, 2024 | Diagnostic Technologies |
Researchers developed new test strips that are just as accurate as the lab-based PCR tests but offer rapid, on-the-spot disease detection.
Read MorePosted by Andy Lundin | Mar 4, 2024 | Diagnostic Technologies, Respiratory Disease |
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Read More